The risks of prescription drugs
I tiakina i:
Kaituhi rangatōpū: | ebrary, Inc |
---|---|
Ētahi atu kaituhi: | Light, Donald, 1942- |
Hōputu: | Tāhiko īPukapuka |
Reo: | Ingarihi |
I whakaputaina: |
New York :
Columbia University Press,
2010.
|
Rangatū: | Columbia University Press and Social Science Research Council series on the privatization of risk.
Columbia/SSRC book. |
Ngā marau: | |
Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
The future of drug safety promoting and protecting the health of the public /
I whakaputaina: (2007)
I whakaputaina: (2007)
Reputation and power organizational image and pharmaceutical regulation at the FDA
mā: Carpenter, Daniel P., 1967-
I whakaputaina: (2010)
mā: Carpenter, Daniel P., 1967-
I whakaputaina: (2010)
How to develop and implement a national drug policy
I whakaputaina: (2001)
I whakaputaina: (2001)
Effective drug regulation a multicountry study /
mā: Ratanawijitrasin, Sauwakon
I whakaputaina: (2002)
mā: Ratanawijitrasin, Sauwakon
I whakaputaina: (2002)
The power of pills social, ethical and legal issues in drug development, marketing, and pricing /
I whakaputaina: (2006)
I whakaputaina: (2006)
Building a national framework for the establishment of regulatory science for drug development workshop summary /
I whakaputaina: (2011)
I whakaputaina: (2011)
Regulating pharmaceuticals in Europe striving for efficiency, equity and quality /
I whakaputaina: (2004)
I whakaputaina: (2004)
Breakthrough business models drug development for rare and neglected diseases and individualized therapies : workshop summary /
I whakaputaina: (2009)
I whakaputaina: (2009)
Coherence for health innovation for new medicines for infectious diseases.
I whakaputaina: (2009)
I whakaputaina: (2009)
Incentives for global public health patent law and access to essential medicines /
I whakaputaina: (2010)
I whakaputaina: (2010)
Pharmaceutical reform a guide to improving performance and equity /
mā: Roberts, Marc J.
I whakaputaina: (2011)
mā: Roberts, Marc J.
I whakaputaina: (2011)
Pharmacy on a bicycle innovative solutions to global health and poverty /
mā: Bing, Eric G.
I whakaputaina: (2013)
mā: Bing, Eric G.
I whakaputaina: (2013)
Generic drugs the pay-for-delay problem /
I whakaputaina: (2011)
I whakaputaina: (2011)
Development and approval of combination products a regulatory perspective /
I whakaputaina: (2008)
I whakaputaina: (2008)
A practical approach to pharmaceutical policy
mā: Seiter, Andreas
I whakaputaina: (2010)
mā: Seiter, Andreas
I whakaputaina: (2010)
Development of FDA-regulated medical products : a translational approach /
mā: Whitmore, Elaine
I whakaputaina: (2012)
mā: Whitmore, Elaine
I whakaputaina: (2012)
Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)
mā: Ng, Rick
I whakaputaina: (2015)
Risk management applications in pharmaceutical and biopharmaceutical manufacturing
I whakaputaina: (2013)
I whakaputaina: (2013)
ADME-enabling technologies for drug design and development
I whakaputaina: (2012)
I whakaputaina: (2012)
Pharmaceutical pricing policies in a global market
I whakaputaina: (2008)
I whakaputaina: (2008)
Les prix des medicaments sur un marche global politiques et enjeux.
I whakaputaina: (2008)
I whakaputaina: (2008)
Access to medicines and vaccines in the South : coherence of rules and policies applied by the European Union Commission /
mā: Kingah, Stephen
I whakaputaina: (2011)
mā: Kingah, Stephen
I whakaputaina: (2011)
Pharmaceutical blending and mixing /
I whakaputaina: (2015)
I whakaputaina: (2015)
Towards drugs of the future key issues in lead finding and lead optimization /
I whakaputaina: (2008)
I whakaputaina: (2008)
Of medicines and markets intellectual property and human rights in the free trade era /
mā: Godoy, Angelina Snodgrass
I whakaputaina: (2013)
mā: Godoy, Angelina Snodgrass
I whakaputaina: (2013)
Drug discovery and design medical aspects /
I whakaputaina: (2002)
I whakaputaina: (2002)
Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)
I whakaputaina: (2013)
Modern drug synthesis
I whakaputaina: (2010)
I whakaputaina: (2010)
The art of drug synthesis
I whakaputaina: (2007)
I whakaputaina: (2007)
Successful drug discovery.
I whakaputaina: (2015)
I whakaputaina: (2015)
Chemical drug design /
I whakaputaina: (2016)
I whakaputaina: (2016)
Negotiating health : intellectual property and access to medicines /
I whakaputaina: (2006)
I whakaputaina: (2006)
Frontiers in drug design and discovery.
I whakaputaina: (2010)
I whakaputaina: (2010)
Case studies in modern drug discovery and development
I whakaputaina: (2012)
I whakaputaina: (2012)
The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
Therapeutic targets modulation, inhibition, and activation /
I whakaputaina: (2012)
I whakaputaina: (2012)
Manufacturing of pharmaceutical proteins : from technology to economy /
mā: Behme, Stefan
I whakaputaina: (2015)
mā: Behme, Stefan
I whakaputaina: (2015)
Drug repositioning bringing new life to shelved assets and existing drugs /
I whakaputaina: (2012)
I whakaputaina: (2012)
Drug delivery principles and applications /
mā: Wang, Binghe
I whakaputaina: (2005)
mā: Wang, Binghe
I whakaputaina: (2005)
Drug delivery : principles and applications /
I whakaputaina: (2016)
I whakaputaina: (2016)
Ngā tūemi rite
-
The future of drug safety promoting and protecting the health of the public /
I whakaputaina: (2007) -
Reputation and power organizational image and pharmaceutical regulation at the FDA
mā: Carpenter, Daniel P., 1967-
I whakaputaina: (2010) -
How to develop and implement a national drug policy
I whakaputaina: (2001) -
Effective drug regulation a multicountry study /
mā: Ratanawijitrasin, Sauwakon
I whakaputaina: (2002) -
The power of pills social, ethical and legal issues in drug development, marketing, and pricing /
I whakaputaina: (2006)